Jean-Claude Horiot

10.4k total citations · 4 hit papers
108 papers, 7.1k citations indexed

About

Jean-Claude Horiot is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jean-Claude Horiot has authored 108 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 34 papers in Surgery and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean-Claude Horiot's work include Advanced Radiotherapy Techniques (28 papers), Head and Neck Cancer Studies (21 papers) and Colorectal and Anal Carcinomas (20 papers). Jean-Claude Horiot is often cited by papers focused on Advanced Radiotherapy Techniques (28 papers), Head and Neck Cancer Studies (21 papers) and Colorectal and Anal Carcinomas (20 papers). Jean-Claude Horiot collaborates with scholars based in France, Netherlands and Belgium. Jean-Claude Horiot's co-authors include Harry Bartelink, Laurence Collette, M. Piérart, Walter Van den Bogaert, H. Struikmans, Philip Poortmans, Alain Fourquet, J.J. Jager, W.J. Hoogenraad and M. Bolla and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Jean-Claude Horiot

106 papers receiving 6.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

2006 752 citations Jacques Bernier, Jean-Claude Horiot et al. profile →
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

2007 722 citations Harry Bartelink, Jean-Claude Horiot et al. profile →
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

2001 693 citations Harry Bartelink, Jean-Claude Horiot et al. profile →
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1992 496 citations Jean-Claude Horiot, R. Le Fur et al. Radiotherapy and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean-Claude Horiot France	38	2.6k	2.5k	2.2k	2.0k	2.0k	108	7.1k
Richard Fisher Australia	37	2.0k 0.8×	1.1k 0.4×	2.5k 1.1×	1.8k 0.9×	1.3k 0.7×	112	6.2k
Walter Van den Bogaert Belgium	41	1.7k 0.6×	2.1k 0.9×	1.8k 0.8×	2.4k 1.2×	1.7k 0.9×	78	6.8k
Lorenzo Livi Italy	36	1.2k 0.4×	1.7k 0.7×	1.7k 0.8×	2.6k 1.3×	558 0.3×	391	6.0k
Jennifer Moughan United States	34	2.2k 0.9×	757 0.3×	1.5k 0.7×	2.1k 1.1×	1.1k 0.6×	123	4.9k
Jürgen Dunst Germany	45	2.4k 0.9×	1.6k 0.7×	1.8k 0.8×	3.0k 1.5×	320 0.2×	234	6.9k
D. Azria France	46	2.3k 0.9×	1.7k 0.7×	3.4k 1.5×	2.8k 1.4×	332 0.2×	372	7.6k
Thomas J. Keane Canada	37	1.8k 0.7×	471 0.2×	1.4k 0.6×	1.6k 0.8×	1.2k 0.6×	80	4.3k
Víctor A. Marcial Puerto Rico	38	1.8k 0.7×	447 0.2×	1.4k 0.6×	1.3k 0.7×	2.2k 1.1×	102	4.2k
Mohammed Mohiuddin United States	51	5.3k 2.0×	559 0.2×	5.4k 2.5×	3.3k 1.6×	764 0.4×	192	9.9k
G. Calais France	39	5.1k 1.9×	630 0.3×	5.2k 2.4×	2.5k 1.2×	2.7k 1.4×	179	8.3k

Countries citing papers authored by Jean-Claude Horiot

Since Specialization

Citations

This map shows the geographic impact of Jean-Claude Horiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Claude Horiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Claude Horiot more than expected).

Fields of papers citing papers by Jean-Claude Horiot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Claude Horiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Claude Horiot. The network helps show where Jean-Claude Horiot may publish in the future.

Co-authorship network of co-authors of Jean-Claude Horiot

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Claude Horiot. A scholar is included among the top collaborators of Jean-Claude Horiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Claude Horiot. Jean-Claude Horiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collette, Sandra, Laurence Collette, Tom Budiharto, et al.. (2008). Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’. European Journal of Cancer. 44(17). 2587–2599. 157 indexed citations

Poortmans, Philip, et al.. (2005). The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future. European Journal of Surgical Oncology. 31(6). 667–674. 17 indexed citations

Budach, Volker, Alfredo Zurlo, & Jean-Claude Horiot. (2002). EORTC Radiotherapy Group: achievements and future projects. European Journal of Cancer. 38. 134–137. 10 indexed citations

Bernier, Jacques, Jean-Claude Horiot, & P Poortmans. (2002). Quality assurance in radiotherapy: from radiation physics to patient- and trial-oriented control procedures. European Journal of Cancer. 38. 155–158. 20 indexed citations

Truc, G., Jean-Claude Horiot, P. Maingon, & I. Barillot. (2000). Le cancer épidermoïde de l'oropharynx. Bulletin du Cancer. 87(12). 9–20. 2 indexed citations

Barillot, I., et al.. (2000). Bilan de l'utilisation de l'imagerie électronique. Cancer/Radiothérapie. 4. 1 indexed citations

Bentzen, Søren M., Jacques Bernier, J.B. Davis, et al.. (2000). Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer. European Journal of Cancer. 36(5). 615–620. 53 indexed citations

Bosset, Jean-François, V. Magnin, P. Maingon, et al.. (2000). Preoperative radiochemotherapy in rectal cancer:. International Journal of Radiation Oncology*Biology*Physics. 46(2). 323–327. 126 indexed citations

Maingon, P., Jean-Claude Horiot, J. Fraisse, et al.. (1996). Preoperative radiotherapy in stage I/II endometrial adenocarcinoma. Radiotherapy and Oncology. 39(3). 201–208. 13 indexed citations

10.

Bernier, Jacques, Jean-Claude Horiot, Harry Bartelink, et al.. (1996). Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer. International Journal of Radiation Oncology*Biology*Physics. 34(4). 953–960. 37 indexed citations

11.

Horiot, Jean-Claude, Jean-François Bosset, & P. Maingon. (1995). Improvement of the curative management of rectal cancers by better use of radiotherapy. European Journal of Cancer. 31(7-8). 1382–1384. 4 indexed citations

12.

Horiot, Jean-Claude, et al.. (1995). Conservative and curative management of rectal adenocarcinomas by local radiotherapy alone. European Journal of Cancer. 31(7-8). 1340–1342. 6 indexed citations

13.

Barillot, I., et al.. (1994). Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiotherapy and Oncology. 30(3). 231–238. 66 indexed citations

14.

Bogaert, W. Van den, M. van Glabbeke, M. Piérart, et al.. (1994). Patient population analysis in eortc trial 22881/10882 on the role of a booster dose in breast-conserving therapy. European Journal of Cancer. 30(14). 2073–2081. 22 indexed citations

15.

Horiot, Jean-Claude, Emmanuel van der Schueren, Kjell Arne Johansson, Jacques Bernier, & Harry Bartelink. (1993). The programme of quality assurance of the EORTC radiotherapy group. A historical overview. Radiotherapy and Oncology. 29(2). 81–84. 41 indexed citations

16.

Horiot, Jean-Claude. (1991). What has radiation biology contributed to the evolution of radiotherapy?. European Journal of Cancer and Clinical Oncology. 27(3). 399–402. 1 indexed citations

17.

Horiot, Jean-Claude. (1991). Rationale for a quality assurance programme in clinical trials of conservative management of breast carcinoma. Radiotherapy and Oncology. 22(4). 222–225. 15 indexed citations

18.

Horiot, Jean-Claude, R. Le Fur, T. Nguyen, et al.. (1990). Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. European Journal of Cancer and Clinical Oncology. 26(7). 779–780. 48 indexed citations

19.

Roth, Stephan, et al.. (1988). Results of Endocavitary Irradiation of Early Rectal Tumors. Acta Oncologica. 27(6). 825–827. 7 indexed citations

20.

Haie, C., George M. Varghese, M.H. Pejovic, et al.. (1988). Feasibility study of an alternating schedule of radiotherapy and chemotherapy in advanced uterine cervical carcinoma. Radiotherapy and Oncology. 12(2). 121–127. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact